Mesothelioma News

Dad to take fight right to top
Evening Gazette - Oct 06 5:41 AM
A desperate father-of-four refused vital cancer treatment on Teesside has vowed to take his fight to the European Court of Human Rights.Save to My Web

Julius Kimerling
British Medical Journal - Sep 22 3:53 PM
General practitioner Kensington, London (b Lvov 1937; q Guy's Hospital 1961; MRCP), died from mesothelioma on 1 July 2005. After house jobs in London Julius was medical registrar at St Mary's Hospital, Paddington.Save to My Web

Asbestos sufferers' support to be extended
Daily Yomiuri Online - Sep 16 11:37 AM
A proposed law will extend the period of compensation currently received by those who suffer asbestos-linked illnesses. The Environment Ministry and the Health, Labor and Welfare Ministry have compiled an outline of the law and started discussions with the ruling parties.Save to My Web

Cover Story: Dying man's torment
Asahi Shimbun, Japan - Sep 13, 2005 It turned out to be malignant pleural mesothelioma. Neither Isamu nor his wife, Chisato, had heard of the disease. Said Chisato, 58: "Why, why, why?

Information About Malignant Mesothelioma
Community Dispatch (press release) - Sep 29, 2005 By National Cancer Institute. Malignant mesothelioma is a disease in which malignant (cancer) cells form in the lining of the chest or abdomen.

Mesothelioma: Questions and Answers
Community Dispatch (press release) - Sep 24, 2005 Mesothelioma is a rare form of cancer in which malignant (cancerous) cells are found in the mesothelium, a protective sac that covers most of the body's

New Publication in Leading Cancer Journal Highlights Effectiveness
PharmaLive.com (press release), PA - Sep 26, 2005 ONCONASE, currently being evaluated in a Phase IIIb confirmatory trial in malignant mesothelioma and a Phase I / II trial in non-small cell lung cancer (NSCLC

Tomudex Plus Platinol Improves Survival of Patients with
Cancer Consultants (press release), TN - Oct 3, 2005 that the combination of Tomudex (raltitrexed) and Platinol (cisplatin) improves survival of patients with malignant pleural mesothelioma (MPM) compared to